- Home
- PESI vs EVMN Comparison
PESI vs EVMN Comparison
Compare PESI & EVMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PESI | EVMN |
|---|---|---|
| Founded | 1990 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Environmental Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 367.9M | 405.2M |
| IPO Year | 1996 | 2025 |
Fundamental Metrics
Financial Performance| Metric | PESI | EVMN |
|---|---|---|
| Price | $17.30 | $14.02 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $43.88 |
| AVG Volume (30 Days) | 466.4K | ★ 480.4K |
| Earning Date | 05-08-2026 | 06-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 43.61 | ★ 75.23 |
| EPS | ★ N/A | N/A |
| Revenue | $642,000.00 | ★ $13,000,000.00 |
| Revenue This Year | $34.62 | N/A |
| Revenue Next Year | $77.02 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 85.71 |
| 52 Week Low | $8.14 | $10.47 |
| 52 Week High | $21.32 | $33.20 |
Technical Indicators
Market Signals| Indicator | PESI | EVMN |
|---|---|---|
| Relative Strength Index (RSI) | 53.65 | 50.34 |
| Support Level | $14.18 | $13.89 |
| Resistance Level | $18.40 | $21.21 |
| Average True Range (ATR) | 1.22 | 0.77 |
| MACD | -0.25 | 0.25 |
| Stochastic Oscillator | 14.14 | 65.79 |
Price Performance
Historical ComparisonAbout PESI Perma-Fix Environmental Services Inc.
Perma-Fix Environmental Services Inc is a nuclear services company and provider of nuclear and mixed waste management services. The company's nuclear waste services include treatment and management of radioactive and mixed waste (waste containing both hazardous and low-level radioactive waste). The company operates through two segments: i) The treatment segment: It offers nuclear, low-level radioactive, Mixed, hazardous and non-hazardous waste treatment, processing and disposal services, and ii) the Services segment which generates the majority of the revenue, provides on-site waste management services to commercial and government customers, technology-based services, construction, logistics, and transportation services among others.
About EVMN Evommune Inc.
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.